Deciphera Pharmaceuticals (STU:D05) Other Long Term Assets : €7.5 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Deciphera Pharmaceuticals Other Long Term Assets?

Deciphera Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2024 was €7.5 Mil.

Deciphera Pharmaceuticals's quarterly other long-term assets increased from Sep. 2023 (€3.1 Mil) to Dec. 2023 (€7.6 Mil) but then stayed the same from Dec. 2023 (€7.6 Mil) to Mar. 2024 (€7.5 Mil).

Deciphera Pharmaceuticals's annual other long-term assets increased from Dec. 2021 (€2.8 Mil) to Dec. 2022 (€3.1 Mil) and increased from Dec. 2022 (€3.1 Mil) to Dec. 2023 (€7.6 Mil).

Deciphera Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Deciphera Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deciphera Pharmaceuticals Other Long Term Assets Chart

Deciphera Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1.36

2.55

2.75

3.09

7.59

Deciphera Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															3.06	3.08	3.13	7.59	7.48

Deciphera Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Deciphera Pharmaceuticals (STU:D05) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deciphera Pharmaceuticals Inc (STU:D05) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

DCPH:USA D05:Germany

Address

200 Smith Street, Waltham, MA, USA, 02451

Website

https://www.deciphera.com

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.

Deciphera Pharmaceuticals (STU:D05) Headlines

No Headlines